Amylyx Pharmaceuticals Inc
(NAS:AMLX)
$
2.16
0 (0%)
Market Cap: 146.89 Mil
Enterprise Value: -222.37 Mil
PE Ratio: 0
PB Ratio: 0.45
GF Score: 21/100 Amylyx Pharmaceuticals Inc (AMLX) Transcripts
- Q4 2023 Amylyx Pharmaceuticals Inc Earnings Call TranscriptFeb 22, 2024$18.54 (+21.10%)Earnings
- Q3 2023 Amylyx Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2023$12.26 (-31.89%)Earnings
- Amylyx Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Amylyx Pharmaceuticals Inc Earnings Call TranscriptAug 10, 2023$21.17 (-1.49%)Earnings
- Amylyx Pharmaceuticals Inc To Host Virtual Webcast on AMX0035 Progressive Supranuclear Palsy (PSP) Program TranscriptJul 26, 2023
- Amylyx Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Amylyx Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 08, 2023
- Q1 2023 Amylyx Pharmaceuticals Inc Earnings Call TranscriptMay 11, 2023$28.82 (-0.41%)Earnings
- Amylyx Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 18, 2023
- Amylyx Pharmaceuticals Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Q4 2022 Amylyx Pharmaceuticals Inc Earnings Call TranscriptMar 13, 2023$31.17 (+1.66%)Earnings
- Amylyx Pharmaceuticals Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 14, 2023
- Amylyx Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 Amylyx Pharmaceuticals Inc Earnings Call TranscriptNov 10, 2022$35.39 (+2.25%)Earnings
- Amylyx Pharmaceuticals Inc RELYVRIOâ„¢ FDA Approval Call TranscriptSep 30, 2022
- Amylyx Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 09, 2022
- 1